NasdaqGM:LFMDHealthcare Services
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership
LifeMD (LFMD) is back in focus after its latest earnings, where the telehealth provider reported full year 2025 net income of US$14.35 million and issued fresh 2026 revenue guidance.
See our latest analysis for LifeMD.
LifeMD’s latest earnings and 2026 guidance have arrived after a sharp recent move, with a 7 day share price return of 31.17% and a 30 day share price return of 29.02% despite a 1 year total shareholder return decline of 30.48%. Short term momentum is building, while the longer...